Xtl Biopharmaceuticals Ltd Stock Price on December 31, 2023
| XTLB Stock | USD 2.42 0.02 0.83% |
Below is the normalized historical share price chart for XTL Biopharmaceuticals Ltd extending back to September 01, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of XTL Biopharmaceutica stands at 2.42, as last reported on the 30th of April, with the highest price reaching 2.51 and the lowest price hitting 2.42 during the day.
If you're considering investing in XTL Stock, it is important to understand the factors that can impact its price. XTL Biopharmaceutica is abnormally volatile given 3 months investment horizon. XTL Biopharmaceuticals shows Sharpe Ratio of 0.15, which attests that the company had a 0.15% return per unit of standard deviation over the last 3 months. We were able to break down and interpolate thirty different technical indicators, which can help you to evaluate if expected returns of 2.56% are justified by taking the suggested risk. Use XTL Biopharmaceuticals Ltd Risk Adjusted Performance of 0.1008, mean deviation of 7.11, and Downside Deviation of 6.19 to evaluate company specific risk that cannot be diversified away.
At present, XTL Biopharmaceutica's Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 17 M, whereas Total Stockholder Equity is forecasted to decline to about 3.4 M. . The current year's Price To Sales Ratio is expected to grow to -15.69. In addition to that, Price Earnings Ratio is expected to decline to -2.7. XTL Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 1st of September 2005 | 200 Day MA 1.1814 | 50 Day MA 1.9258 | Beta 1.026 |
XTL |
Sharpe Ratio = 0.1455
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | XTLB | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 17.59 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.56 actual daily | 50 50% of assets have lower returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average XTL Biopharmaceutica is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of XTL Biopharmaceutica by adding it to a well-diversified portfolio.
Price Book 5.6648 | Book Value 0.005 | Enterprise Value 1.3 B | Enterprise Value Ebitda (6.58) | Shares Float 413.3 M |
XTL Biopharmaceutica Valuation on December 31, 2023
It is possible to determine the worth of XTL Biopharmaceutica on a given historical date. On December 31, 2023 XTL was worth 0.81 at the beginning of the trading date compared to the closed value of 1.01. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of XTL Biopharmaceutica stock. Still, in general, we apply an absolute valuation method to find XTL Biopharmaceutica's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of XTL Biopharmaceutica where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against XTL Biopharmaceutica's related companies.
| Open | High | Low | Close | Volume | |
| 1.08 | 1.08 | 1.00 | 1.00 | 3,254 | |
12/29/2023 | 0.81 | 1.05 | 0.81 | 1.01 | 6,100 |
| 0.91 | 0.98 | 0.91 | 0.98 | 529.00 |
| Backtest XTL Biopharmaceutica | | | XTL Biopharmaceutica History | | | XTL Biopharmaceutica Valuation | Previous | Next |
XTL Biopharmaceutica Trading Date Momentum on December 31, 2023
| On January 02 2024 XTL Biopharmaceuticals Ltd was traded for 0.98 at the closing time. The top price for the day was 0.98 and the lowest listed price was 0.91 . The trading volume for the day was 529. The trading history from January 2, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 2.97% . The trading price change against the current closing price is 0.99% . |
XTL Biopharmaceuticals Fundamentals Correlations and Trends
By evaluating XTL Biopharmaceutica's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among XTL Biopharmaceutica's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. XTL financial account trend analysis is a perfect complement when working with valuation or volatility modules.About XTL Biopharmaceutica Stock history
XTL Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for XTL is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in XTL Biopharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing XTL Biopharmaceutica stock prices may prove useful in developing a viable investing in XTL Biopharmaceutica
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.9 M | 4.7 M | |
| Net Loss | -1.6 M | -1.6 M |
XTL Biopharmaceutica Quarterly Net Working Capital |
|
XTL Biopharmaceutica Stock Technical Analysis
XTL Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
XTL Biopharmaceutica Period Price Range
Low | December 29, 2023
| High |
0.81 | 1.01 |
XTL Biopharmaceutica April 30, 2024 Market Strength
Market strength indicators help investors to evaluate how XTL Biopharmaceutica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading XTL Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying XTL Biopharmaceutica stock market strength indicators, traders can identify XTL Biopharmaceuticals Ltd entry and exit signals to maximize returns
XTL Biopharmaceutica Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for XTL Biopharmaceutica's price direction in advance. Along with the technical and fundamental analysis of XTL Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of XTL to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1008 | |||
| Jensen Alpha | 2.36 | |||
| Total Risk Alpha | 1.11 | |||
| Sortino Ratio | 0.3853 | |||
| Treynor Ratio | 1.6 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XTL Biopharmaceuticals Ltd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for XTL Stock analysis
When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is XTL Biopharmaceutica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of XTL Biopharmaceutica. If investors know XTL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about XTL Biopharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Earnings Share (0.40) | Return On Assets (0.13) | Return On Equity (0.62) |
The market value of XTL Biopharmaceuticals is measured differently than its book value, which is the value of XTL that is recorded on the company's balance sheet. Investors also form their own opinion of XTL Biopharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is XTL Biopharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because XTL Biopharmaceutica's market value can be influenced by many factors that don't directly affect XTL Biopharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between XTL Biopharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if XTL Biopharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XTL Biopharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.